Influence of Programmed Death Ligand-1-Gene Polymorphism rs822336 on the Prognosis and Safety of Postoperative Patients with NSCLC Who Received Platinum-Based Adjuvant Chemotherapy
Ming Zhao,1,* Jing Zhang,1,* Siyu Chen,2,* Yuqi Wang,1 Qing Tian1 1Department of Thoracic Surgery, The General Hospital of the People’s Liberation Army, Beijing, 100853, People’s Republic of China; 2Department of Thoracic Surgery, The Sixth Medical Center of PLA General Hospital,...
Main Authors: | Zhao M, Zhang J, Chen S, Wang Y, Tian Q |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-08-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/influence-of-programmed-death-ligand-1-gene-polymorphism-rs822336-on-t-peer-reviewed-article-CMAR |
Similar Items
-
Prognostic significance of galectin‐3 expression in patients with resected NSCLC treated with platinum‐based adjuvant chemotherapy
by: Seiichiro Kusuhara, et al.
Published: (2021-05-01) -
Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy
by: Emilia Montagna, et al.
Published: (2020-10-01) -
Role of paclitaxel and platinum-based adjuvant chemotherapy in high-risk penile cancer
by: Vanita Noronha, et al.
Published: (2012-01-01) -
Effect of Adjuvant Chemotherapy on DFS for Patients with Stage I NSCLC
by: Shengzu PENG, et al.
Published: (2017-06-01) -
Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC
by: Katsurada N, et al.
Published: (2020-02-01)